Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

New Nav options
November 2015
SHARING OPTIONS:

CAMBRIDGE, Mass. & DURHAM, N.C.—Icagen Inc. kicked off October by launching access to its sodium channel platform, comprised of a portfolio of cell lines, reagents and assays, enabling clients to access resources within the portfolio or work with Icagen to create custom sodium channel cell lines and assays. The company says it has established the most extensive collection of cell lines that stably express functional Nav Channels, including human Nav1.1-Nav1.9, species orthologs (human, cynomologous monkey, marmoset, pig, dog, rat, mouse), distinct disease-related or drug binding site Nav channel mutants, as well as a broad set of validated functional fluorescence, flux and electrophysiological assays.
 
“We are now offering the opportunity for others within the pharmaceutical industry to benefit from our expertise in this field, as well as access our full range of Nav research tools for their own drug discovery and development efforts,” said Neil Castle, director of biology at Icagen.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.